Electric shocks + chemo: new hope for liver tumors?

NCT ID NCT05267080

Ongoing Knowledge-focused Sponsor: Cardiovascular and Interventional Radiological Society of Europe Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that collects information on how well electrochemotherapy (ECT) works for people with liver cancer. ECT uses short electric pulses to help chemotherapy drugs enter cancer cells more effectively. The study will follow 250 adults with primary or secondary liver cancer who are already scheduled to receive ECT, tracking tumor control, side effects, and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY LIVER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma liver cancer secondary malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY LIVER CANCER SECONDARY LIVER CANCER

Contacts and locations

Locations

Centre Hospitalier Universitaire de Montpellier

Montpellier, France
Fondazione Policlinico Universitario Campus Bio-Medico

Rome, Italy
Helios Park-Klinikum

Leipzig, Germany
Hospital Universitario y Politécnico La Fe

Valencia, Spain
Hôpital Européen Georges-Pompidou

Paris, France
Institut Gustave Roussy

Paris, France
Istituto Europeo di Oncologia

Milan, Italy
Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom
Policlinico Universitario A. Gemelli

Rome, Italy
Städtisches Klinikum Braunschweig

Braunschweig, Germany
University Hospital Regensburg

Regensburg, Germany
University of Szeged

Szeged, Hungary
Universitätsklinikum Halle

Halle, Germany
Vilnius University Hospital Santariškių Klinikos

Vilnius, Lithuania
WEGE Klinik

Bonn, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.